Successful management of therapy‐related chronic myelomonocytic leukemia with cytarabine, aclarubicin, and azacitidine following tegafur/gimeracil/oteracil

A 55‐year‐old man was diagnosed with therapy‐related chronic myelomonocytic leukemia (t‐CMML) after exposure to tegafur/gimeracil/oteracil. Although he was refractory to hydroxyurea and low‐dose cytarabine, combination therapy with cytarabine, aclarubicin and azacitidine (CA‐AZA) provided good disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakako, Soichiro, Takakuwa, Teruhito, Ichimura, Hirona, Okamura, Hiroshi, Nanno, Satoru, Nishimoto, Mitsutaka, Nakashima, Yasuhiro, Koh, Hideo, Hino, Masayuki, Nakamae, Hirohisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223688/
https://www.ncbi.nlm.nih.gov/pubmed/34194799
http://dx.doi.org/10.1002/ccr3.4298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223688/
https://www.ncbi.nlm.nih.gov/pubmed/34194799
http://dx.doi.org/10.1002/ccr3.4298

Ejemplares similares